Sign inJoin waitlistJoin the waitlist

Amer Beitinjaneh

Core Faculty & Site Director, Bone Marrow Transplant · Broward Health

Credentials: · · · · ·

History

&, Bone Marrow Transplant · Broward Health
Present
University of Miami/Jackson Health System
Present

Hematology
2003–2004
Internal Medicine
George Washington University School of Medicine
2000–2003
Tishreen University Faculty of Medicine
1996–2000

Research

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · 1,512 citations
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Journal of Clinical Oncology · 2023 · 292 citations
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Blood · 2017 · 256 citations

Hillard Lazarus
50 papers
TN
Taiga Nishihori
49 papers
Siddhartha Ganguly
46 papers
BS
Bipin Savani
43 papers
Jean Yared
38 papers
BW
Baldeep Wirk
37 papers
SH
Shahrukh Hashmi
33 papers
Gerhard Hildebrandt
31 papers
Saurabh Chhabra
30 papers
Wael Saber
30 papers
Mohamed Dabaja
28 papers
Lazaros Lekakis
27 papers

Clinical trials

Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
Principal investigator · Terminated · Phase 2
University of Virginia
2012–2017
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
Site PI · Recruiting · Phase 1
Huda Salman
2024–2042
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
Site PI · Recruiting · Phase 1
Huda Salman
2024–2043
CD4CAR for CD4+ Leukemia and Lymphoma
Site PI · Recruiting · Phase 1
Huda Salman
2020–2042